Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis.

Korotchkina L, Kazyulkin D, Komarov PG, Polinsky A, Andrianova EL, Joshi S, Gupta M, Vujcic S, Kononov E, Toshkov I, Tian Y, Krasnov P, Chernov MV, Veith J, Antoch MP, Middlemiss S, Somers K, Lock RB, Norris MD, Henderson MJ, Haber M, Chernova OB, Gudkov AV.

Leukemia. 2020 Jan 2. doi: 10.1038/s41375-019-0692-5. [Epub ahead of print]

PMID:
31896781
2.

Development of a High-Throughput Biochemical Assay to Screen for Inhibitors of Aerobactin Synthetase IucA.

Bailey DC, Buckley BP, Chernov MV, Gulick AM.

SLAS Discov. 2018 Dec;23(10):1070-1082. doi: 10.1177/2472555218787140. Epub 2018 Jul 10.

3.

Targeting RING domains of Mdm2-MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells.

Wu W, Xu C, Ling X, Fan C, Buckley BP, Chernov MV, Ellis L, Li F, Muñoz IG, Wang X.

Cell Death Dis. 2015 Dec 31;6:e2035. doi: 10.1038/cddis.2015.358.

4.

Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1.

Hu Y, Spengler ML, Kuropatwinski KK, Comas-Soberats M, Jackson M, Chernov MV, Gleiberman AS, Fedtsova N, Rustum YM, Gudkov AV, Antoch MP.

Oncotarget. 2011 Dec;2(12):1279-90.

5.

Pharmacological modulators of the circadian clock as potential therapeutic drugs.

Antoch MP, Chernov MV.

Mutat Res. 2009 Nov-Dec;680(1-2):109-15. Review.

PMID:
20336820
6.

Pharmacological modulators of the circadian clock as potential therapeutic drugs.

Antoch MP, Chernov MV.

Mutat Res. 2009 Sep;679(1-2):17-23. Epub 2009 Aug 14.

7.

Post-translational regulation of circadian transcriptional CLOCK(NPAS2)/BMAL1 complex by CRYPTOCHROMES.

Kondratov RV, Kondratova AA, Lee C, Gorbacheva VY, Chernov MV, Antoch MP.

Cell Cycle. 2006 Apr;5(8):890-5. Epub 2006 Apr 17.

PMID:
16628007
8.

[Assessment of the value of new methods for diagnostics and treatment of diseases of anhepatic biliary ducts].

Rozikov IuSh, Galaeva EV, Chernov MV, Mal'tseva IM.

Eksp Klin Gastroenterol. 2005;(2):59-63. Russian.

PMID:
15932157
9.

p53 is a suppressor of inflammatory response in mice.

Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, Komarov PG, Brennan ML, Golovkina TV, Rokhlin OW, Kuprash DV, Nedospasov SA, Hazen SL, Feinstein E, Gudkov AV.

FASEB J. 2005 Jun;19(8):1030-2. Epub 2005 Apr 5.

PMID:
15811878
10.

Selection-subtraction approach (SSA): a universal genetic screening technique that enables negative selection.

Singhi AD, Kondratov RV, Neznanov N, Chernov MV, Gudkov AV.

Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9327-32. Epub 2004 Jun 8.

11.
12.

p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways.

Komarova EA, Neznanov N, Komarov PG, Chernov MV, Wang K, Gudkov AV.

J Biol Chem. 2003 May 2;278(18):15465-8. Epub 2003 Mar 12.

13.

Regulation of ubiquitination and degradation of p53 in unstressed cells through C-terminal phosphorylation.

Chernov MV, Bean LJ, Lerner N, Stark GR.

J Biol Chem. 2001 Aug 24;276(34):31819-24. Epub 2001 Jun 28.

14.

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV, Gudkov AV.

Science. 1999 Sep 10;285(5434):1733-7.

15.

Stabilization and activation of p53 are regulated independently by different phosphorylation events.

Chernov MV, Ramana CV, Adler VV, Stark GR.

Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2284-9.

16.

The p53 network.

Agarwal ML, Taylor WR, Chernov MV, Chernova OB, Stark GR.

J Biol Chem. 1998 Jan 2;273(1):1-4. Review. No abstract available.

17.

The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV.

Nature. 1998 Jan 15;391(6664):295-8.

PMID:
9440695
18.

MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.

Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR.

Mol Cell Biol. 1998 Jan;18(1):536-45.

19.
20.

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.

Komarova EA, Chernov MV, Franks R, Wang K, Armin G, Zelnick CR, Chin DM, Bacus SS, Stark GR, Gudkov AV.

EMBO J. 1997 Mar 17;16(6):1391-400.

21.

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14.

22.

The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited.

Chernova OB, Chernov MV, Agarwal ML, Taylor WR, Stark GR.

Trends Biochem Sci. 1995 Oct;20(10):431-4. Review.

PMID:
8533158
23.

p53-dependent growth arrest of REF52 cells containing newly amplified DNA.

Ishizaka Y, Chernov MV, Burns CM, Stark GR.

Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3224-8.

24.

Regulation and mechanisms of gene amplification.

Smith KA, Agarwal ML, Chernov MV, Chernova OB, Deguchi Y, Ishizaka Y, Patterson TE, Poupon MF, Stark GR.

Philos Trans R Soc Lond B Biol Sci. 1995 Jan 30;347(1319):49-56. Review.

PMID:
7746853
25.

[The tissue specificity of the expression of the avian sarcoma-leukosis complex viruses].

Zaĭtsevskaia TE, Chernov MV, Komarova EA, Grigorian IA, Denisova RA, Heinar I, Nechiba I, Svoboda J, Gudkov AV.

Dokl Akad Nauk SSSR. 1990;313(4):983-6. Russian. No abstract available.

PMID:
2174768
26.

[Endogenous MMTV in the normal mammary gland and in dimethylanthracene-induced mammary cancer in BALB/c mice].

Komarova EA, Kriukova IN, Chernov MV, Kazarov AR.

Mol Gen Mikrobiol Virusol. 1987 Aug;(8):10-3. Russian.

PMID:
2825005
27.

[The genome of chickens free of endogenous avian leukosis-sarcoma proviruses contains sequences distantly related to Rous sarcoma virus].

Chernov MV, Tikhonenko AT, Zaĭtsevskaia TE, Denisova RA, Obukh IB.

Mol Gen Mikrobiol Virusol. 1987 Mar;(3):6-11. Russian.

PMID:
3033485
28.

[Characteristics of new loci of endogenous proviruses in chickens].

Chernov MV, Gudkov AV, Obukh IB, Denisova RA, Gorbacheva NS.

Vopr Virusol. 1986 Mar-Apr;31(2):216-20. Russian.

PMID:
3014752
29.

Methylation of endogenous proviruses of Brown Leghorn chickens.

Gudkov AV, Chernov MV, Tikhonenko AT, Obukh IB, Hlozánek I.

Folia Biol (Praha). 1986;32(1):73-7.

PMID:
3009240
30.

Genetic structure of the endogenous proviruses and expression of the gag gene in Brown Leghorn chickens.

Gudkov AV, Korec E, Chernov MV, Tikhonenko AT, Obukh IB, Hlozánek I.

Folia Biol (Praha). 1986;32(1):65-72.

PMID:
3009239
31.

[Possible mechanisms of the occurrence of new loci of defective endogenous proviruses].

Tikhonenko AT, Chernov MV, Obukh IB, Gudkov AV.

Dokl Akad Nauk SSSR. 1985;282(5):1259-62. Russian. No abstract available.

PMID:
2994974
32.

[Structural diversity of endogenous proviruses in genomes of vertebrates].

Gudkov AV, Kolobkov SL, Obukh IB, Serov SM, Chernov MV.

Vestn Akad Med Nauk SSSR. 1984;(5):3-9. Russian. No abstract available.

PMID:
6741246
33.
34.
35.

[Labor pains and psychoprophylaxis of birth pains in the light of I.P. Pavlov's theory of the highest nervous activity].

CHERNOV MV.

Dtsch Gesundheitsw. 1953 Jan 8;8(2):40-5. Undetermined Language. No abstract available.

PMID:
13067682

Supplemental Content

Loading ...
Support Center